Skeletal muscle atrophy and fatty infiltration develop after tendon tearing. The extent of atrophy serves as one prognostic factor for the outcome of surgical repair of rotator cuff tendon tears. We asked whether mRNA of genes involved in regulation of degradative processes leading to muscle atrophy, ie, FOXOs, MSTN, calpains, cathepsins, and transcripts of the ubiquitin-proteasome pathway, are overexpressed in the supraspinatus muscle in patients with and without rotator cuff tears. We evaluated biopsy specimens collected during surgery of 53 consecutive patients with different sizes of rotator cuff tendon tears and six without tears. The levels of corresponding gene transcripts in total RNA extracts were assessed by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. Supraspinatus muscle atrophy was assessed by MRI.
Introduction
Atrophy and fatty infiltration of skeletal muscle are consequences of rotator cuff tendon tears in animal models and in humans [4, 14, 26] . Muscle atrophy depends on the size of tear and time elapsed since the tear [13, 26, 34, 42] . Even after structurally successful surgical tendon repair, skeletal muscles of the rotator cuff only partially recover from atrophy [13, 33] . Thus, the original force-generating capacity of the muscle is not restored and muscle function remains restricted. If atrophy could be prevented or reversed, the clinical outcome after rotator cuff tendon repair could be improved.
Skeletal muscle atrophy results from reduced protein synthesis and/or increased protein degradation [16, 23] . Various signaling proteins, such as transcription factors, reportedly regulate skeletal muscle atrophy. In the absence of growth or survival signals, the transcription factor FOXO localizes to the nucleus ( Fig. 1 ) and activates genes involved in cell death and cell cycle inhibition [35] . Specifically, FOXO induces atrogin-1 and MURF1 and thus leads to muscle atrophy [22, 31] . This signaling orchestrates three known proteolytic systems working together in muscle atrophy, ie, the calcium-dependent calpain system, the lysosomal protease system (cathepsins), and the ubiquitin-proteasome system [21] . The ubiquitous calpains (CAPN1 and CAPN2) are involved in the disassembly of sarcomeric proteins in atrophy models [20, 28, 41] . Therefore, myofibrillar proteins become available for ubiquitination, a prerequisite for degradation by proteasomes that are not able to degrade intact myofibrils [1] . Different from the ubiquitous calpains, calpain 3 is not involved in the initial proteolytic events [9] , and may play a role in sarcomere maintenance in mature muscle cells [9] . The conjugation of ubiquitin to proteins in the ubiquitinproteasome system is mediated by a series of sequential reactions conducted by ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin-protein ligases (E3). Proteins ubiquitinated by polyubiquitin chains are recognized and degraded by the proteasome [21] . If the protein substrate is monoubiquitinated or diubiquitinated, it is degraded by the lysosomal pathway [21] . Cathepsins L, B, D, and H are the major lysosomal proteases [3] and have different substrate specificities [24, 27, 32] . They hydrolyze various myofibrillar proteins and are involved in skeletal muscle atrophy [3] .
Although several studies explore acute skeletal muscle atrophy (eg, disuse, spaceflight, immobilization, or denervation [19, 29, 36, 37] , the molecular mechanisms of chronic atrophy after tendon tears are less well understood [11] . We presume an understanding of the cascade(s) of cellular processes that lead to muscle atrophy with tendon damage could lead to focused pharmacologic treatments (eg, proteolysis inhibitors) reversing the atrophy.
We therefore (1) compared the expression levels of the selected gene transcripts of patients with defined rotator cuff defects compared with the respective transcript levels in the supraspinatus muscle of patients with intact rotator cuffs and (2) determined whether the expression varied by cuff size and age.
Materials and Methods
To determine the expression status of genes involved in protein degradation, we enrolled 59 consecutive patients undergoing shoulder surgery: 53 patients had various sizes of tendon tears (Table 1) ; six patients had an intact rotator cuff and underwent surgery for other reasons (impingement syndrome [n = 2], shoulder instability with Bankart lesion [n = 1], acromioclavicular arthropathy [n = 2], and glenohumeral degenerative disease [n = 1]). To examine the influence of defect size, we defined three groups of the 53 patients with rotator cuff tendon tears: tears as much as 1 .
3
of the rotator cuff tendons in sagittal diameter (n = 27), as much as 2 .
3 (n = 13), and full tears (n = 13). Thus, we had four groups: three with varying size tears and one without tears. The median patient age was 57.3 years (range, 27-87 years). There was no difference in the distribution of men and women among the groups without rotator cuff tendon tears and with different sizes of tendon tears in sagittal diameter (Table 1 ). Patients with tendon tears were on average 20 years older (p \ 0.001) than patients with intact tendons. The body mass index (median, 25.7 kg/m 2 ) was not related to the size of the rotator cuff tendon tear. Our power analysis indicated, to detect a threshold of differential expression of 2.5, presuming this increase would influence protein expression and ultimately clinically relevant proteolysis, six patients per group were required. The study was approved by the institutional investigational review board. All patients provided signed informed consent to participate in this study.
We (SS, PS, FR) determined the Constant-Murley score [7] and Goutallier stages on standardized MRI (parasagittal T1-weighted turbo spin echo) preoperatively [10, 17] . Goutallier Stage 0 corresponds to a completely normal muscle, without any fatty streak; Stage 1, the muscle contains some fatty streaks; Stage 2, fatty infiltration is important, but there is still more muscle than fat present; Stage 3, there is as much fat as muscle; and Stage 4, there is more fat than muscle present [17, 18] . For the 59 patients, the Goutallier stage increased with increasing size of the rotator cuff tendon tear (p = 0.002), and the Constant-Murley score also was related to tendon tear size (p = 0.019), with maximal values observed in Group 1 ( Table 1) . To measure the extent of atrophy, we (FR, MZ) determined the muscle cross-sectional area of the supraspinatus in the most lateral MR image where the scapular spine is in contact with the rest of the scapula [34] . This muscle area was standardized to the area of the supraspinatus fossa, which is considered representative for body constitution [42] . Areas were measured on the MR console using the manufacturer's standard software. We found the muscle cross-sectional area standardized to the area of the supraspinatus fossa decreased with increasing tear size (p \ 0.001), indicating ongoing muscle atrophy (Table 1) .
Biopsy specimens of the supraspinatus muscle of approximately 20 mg were collected during surgery (before repair) and sampled immediately thereafter, which was described previously [11] . To avoid the influence on gene expression of muscular inhomogeneity, eg, from different fiber type composition in different parts of the muscle [2, 25] , biopsy specimens always were taken from the same region of the muscle, ie, at the anatomic location which corresponds on MRI to the most lateral part where the scapular spine is in contact with the rest of the scapula to produce a Y-shaped appearance as described previously [11, 42] .
Total RNA was isolated from 25-lm cryosections of the biopsy specimens [11, 40] . Specifically, the integrity of the RNA was analyzed by agarose gel electrophoresis, and RNA concentrations were estimated with the RiboGreen 1 RNA quantification kit (Invitrogen, Carlsbad, CA). The expression levels of transcripts encoding proteins involved in muscle atrophy were analyzed by semiquantitative RT-PCR in triplicate and normalized to glyceraldehyde-3phosphate dehydrogenase (GAPDH) transcript levels for all samples as described previously [8, 11] . Briefly, cDNA was synthesized from individual RNA extracts in triplicate using the StrataScript 1 First Strand cDNA Synthesis kit (Stratagene, La Jolla, CA) with oligo-dT primers and 750 ng total RNA template in a total volume of 50 lL. The primer pairs for PCR amplification of selected gene transcripts were designed with the LightCycler 1 Probe Design Software 2.0 (Roche, Rotkreuz, Switzerland) ( Table 2 ). As quality control for quantification of PCR products in the linear range of amplification, PCR reactions were performed with 4 lL and 8 lL of the RT reaction containing cDNA template equivalent to 5 ng and 10 ng total RNA, respectively, extracted from individual biopsy specimens. The following conditions revealed amplification within the linear range for all selected gene transcripts, indicated by ratios of 2 ± 0.3 between the detected amounts of PCR product of a distinct gene transcript generated in parallel reactions with twofold different amounts of template. After initial denaturation at 94°C for 3 minutes, cDNA representing GAPDH or individual atrophy-related transcripts were amplified by 25 or 35 PCR cycles (denaturation at 94°C for 40 seconds, primer pair-dependent annealing at a specific temperature [ Table 2 ] for 40 seconds, and elongation at 72°C for 20 seconds), respectively. PCR was completed by a final elongation step at 72°C for 7 minutes. [11] . Data are presented as median and 95% confidence interval. We used a chi square test to determine whether the categories of nominal or ordinal scaled data (gender, Goutallier stage, dominance) were distributed equally among the four groups. We used a correlation analysis to determine whether any of the transcripts varied with age.
For the transcripts, the gene expression level of each group was normalized to the median of the control group. We determined the differences in transcript levels of the respective genes of interest with respect to the size of the rotator cuff tendon tear using the Kruskal-Wallis test. We determined differences of gene expression between any two respective groups with differing tear sizes (Table 3) using the Mann-Whitney U test; we did not use post hoc tests for multiple comparisons. We used SPSS 1 for Windows 1 11.5.0 (SPSS Inc, Chicago, IL). 
Results
Several genes involved in protein degradation were upregulated at the mRNA level in the muscles of massive rotator cuff tears (Table 3 ). However, we identified no specific degradation pathway where upregulation was substantially greater than another. Of the transcription factors analyzed in this analysis, FOXO1A was upregulated in the muscles of massive tears compared with smaller tears and controls, whereas FOXO3A was downregulated if the tear became larger than 1 .
3 (Table 3 ). In the calpain group, CAPN1 was upregulated in massive tears. In the ubiquitin-proteasome pathway group, UBE2B and UBE3A were upregulated in the muscles of massive tears compared with smaller tears and controls. In the lysosomal group, CTSB was upregulated in massive tears compared with smaller tears. Of all genes analyzed, CAPN1, UBE2B, and UBE3A were upregulated greater than twofold in the muscles of massive tears compared with smaller tears and controls.
Gene expression of each transcript did not correlate (r 2 \ 0.1) with age ( Fig. 2; Table 4 ). Thus, at most 10% variation of the expression levels could be explained by age of the patients.
Discussion
Rotator cuff tears lead to atrophy, fatty infiltration of skeletal muscles, pain, and loss of shoulder function. Therefore, massive rotator cuff tears with considerable atrophy and high muscular fat content of the corresponding muscles have a poor outcome after surgery. We presume identification of the molecular mechanisms of chronic atrophy could lead to pharmacologic treatments (eg, blocking agents to proteolysis). To recognize indicator molecules for increased muscle structure degradation causing atrophy in supraspinatus muscle of patients with rotator cuff tears, we investigated expression at the transcript level of selected genes, which encode proteins representative of four groups that orchestrate proteolysis. These include transcription factors and proteins representing the calpain, lysosomal, and ubiquitin-proteasome proteolytic pathways.
Owing to limitations of such a study in patients, the findings need critical discussion. Gene expression can be influenced by the timing of responses to injury and we did not know the time that had elapsed between the rotator cuff tendon tear and surgery. By analyzing patients' histories, we estimated the time between tendon tearing until surgery, which ranged from months to years. Therefore, the muscle biopsies performed in our study represent only the chronic phase of atrophy and must be distinguished from the acute phase. Another potential limitation of our study was the age difference in the group with intact rotator cuff versus the other groups with varying sizes of rotator cuff tendon tears because age may influence gene expression of proteins involved in skeletal muscle atrophy [6, 15, 39] . We analyzed expression values using the Kruskal-Wallis test including all four groups together. Additionally, we compared the expression values of each group with any extent of tendon tear with the group with intact tendons and the massive tear group with the next smaller extent of tendon tear. The latter analysis revealed the main differences in expression occurred in massive tears compared with the second largest tear size group. For these two groups, there was no difference in age. Given less than 10% of the variation in expression levels could be explained by age, we presume age is not a causative factor. The significantly upregulated or downregulated gene transcripts we observed indicate altered proteolysis in supraspinatus muscle of patients with a rotator cuff tear. However, the findings must be confirmed at the protein level, and the biological role of these proteins in interaction with cellular mechanisms that contribute to muscle atrophy remain to be investigated because expression at the mRNA level may not correlate with protein expression or biological relevance.
To understand and interpret our findings, the temporal expression patterns of genes must be considered. The expression level of mRNA encoding proteins involved in skeletal muscle atrophy varies with time after a tendon tear. For example, atrogin-1 and MURF1, which represent key regulators of muscle atrophy, appear only transiently elevated during rapid muscle mass loss in the acute phase of skeletal muscle atrophy [5, 30] . Therefore, these two genes showed no changes in expression levels because our analysis included only chronic tears and mRNA levels normalized again after the acute phase. The fact that MURF1 was not upregulated also may reflect the fact that age may not influence our findings as it is upregulated in aged skeletal muscles [6, 15, 39] . Also, the expression of FOXO1A is upregulated in acute tears and persists at an elevated level [30] . These findings may be consistent with our increased expression of FOXO1A. The greatest differential expression was identified in UBE2B and UBE3A, which act in concert in the ubiquitination of soluble muscle proteins and in CAPN1 [38] . We found them upregulated particularly in massive rotator cuff tears. This may indicate it is the UBE genes in the ubiquitin-proteasome pathway and not the atrogin-1 and MURF1 genes which play an important role in mediating the molecular processes of atrophy in massive rotator cuff tears. One key player of the lysosomal pathway, CTSB, also is upregulated. This indicates all gene families involved in protein degradation are represented in the atrophy process in patients with massive rotator cuff tears, suggesting the cellular processes involved in this atrophy are complex and these pathways are orchestrated among each other ( Fig. 1 ). However, in view of this complexity, our analysis represents a preliminary study providing the rationale for in vitro studies that require more detailed analysis at the protein and functional levels to better characterize the role of these genes in the atrophy process of rotator cuff tears. Our data suggest mRNA levels of atrophy-related genes were increased preferentially in biopsy specimens from our patients with large or massive rotator cuff tendon tears. Massive rotator cuff tears were associated with increased muscular atrophy and fatty infiltration [13] . Therefore, the repair of massive tears often is followed by retears of the tendons and accompanied by additional muscular degeneration [13] . Consequently, the outcome after surgical repair of massive tears is often less satisfactory than outcome in patients with smaller tears [12] . Considering the fact that protein degradation genes are overexpressed in the muscles of massive rotator cuff tears, our results parallel the clinical observations of increased atrophy and muscular degeneration in large tears compared with small tears. Therefore, it may be that the activity of atrophy genes in muscles of patients with massive rotator cuff tendon tears may contribute to the unsatisfying results after surgical repair.
We found the transcript levels of distinct genes involved in skeletal muscle atrophy increased in patients with massive rupture of the rotator cuff tendons compared with patients with smaller tears or without tears. Increased activity of these genes may contribute to impaired functional recovery of atrophic muscles after surgical rotator cuff repair. Taken together, the observations suggest upregulation of the transcripts encoding FOXO1A, calpains, UBE2B, UBE3A, and CTSB, which reflect molecular events in the rotator cuff muscle after tendon tears and concomitant muscle atrophy.
